306 related articles for article (PubMed ID: 25043869)
21. A Comparative Study of the Diagnostic and Prognostic Utility of Soluble Urokinase-type Plasminogen Activator Receptor and Procalcitonin in Patients with Sepsis and Systemic Inflammation Response Syndrome.
Sharma A; Ray S; Mamidipalli R; Kakar A; Chugh P; Jain R; Ghalaut MS; Choudhury S
Indian J Crit Care Med; 2020 Apr; 24(4):245-251. PubMed ID: 32565634
[TBL] [Abstract][Full Text] [Related]
22. Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.
Xiao Y; Luo H; Zhou B; Dai X; Huang J; Duan L; You Y; Zhang W; Zhao H; Xie Y; Zhou Y; Ning W; Li T; Liu S; Zhu H; Xie X; Jiang Y; Wu S; He W; Li Y
Rheumatol Int; 2017 Apr; 37(4):585-592. PubMed ID: 27878344
[TBL] [Abstract][Full Text] [Related]
23. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome.
Raggam RB; Wagner J; Prüller F; Grisold A; Leitner E; Zollner-Schwetz I; Valentin T; Krause R; Hoenigl M
J Intern Med; 2014 Dec; 276(6):651-8. PubMed ID: 24645798
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of decoy receptor 3 combined with procalcitonin and soluble urokinase-type plasminogen activator receptor for sepsis.
Zhao JJ; Lou XL; Chen HW; Zhu FT; Hou YQ
Cell Mol Biol Lett; 2018; 23():22. PubMed ID: 29760745
[TBL] [Abstract][Full Text] [Related]
25. The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia.
Erkut N; Menteşe A; Özbaş HM; Ermantaş N; Sümer A; Örem A; Sönmez M
Turk J Haematol; 2016 Jun; 33(2):135-40. PubMed ID: 26376588
[TBL] [Abstract][Full Text] [Related]
26. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission.
Suberviola B; Castellanos-Ortega A; Ruiz Ruiz A; Lopez-Hoyos M; Santibañez M
Intensive Care Med; 2013 Nov; 39(11):1945-52. PubMed ID: 23949703
[TBL] [Abstract][Full Text] [Related]
27. Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory Study.
Nusshag C; Rupp C; Schmitt F; Krautkrämer E; Speer C; Kälble F; Tamulyte S; Bruckner T; Zeier M; Reiser J; Weigand MA; Uhle F; Merle U; Morath C; Brenner T
Crit Care Med; 2019 Dec; 47(12):e999-e1007. PubMed ID: 31584458
[TBL] [Abstract][Full Text] [Related]
28. suPAR as a marker of infection in acute kidney injury - a prospective observational study.
Hall A; Crichton S; Varrier M; Bear DE; Ostermann M
BMC Nephrol; 2018 Aug; 19(1):191. PubMed ID: 30071826
[TBL] [Abstract][Full Text] [Related]
29. Plasma Soluble Urokinase Plasminogen Activator Receptor Levels in Systemic Lupus Erythematosus Patients.
Zaitoon YA; Shehab AA; Mohamed NA; Morad CS; Yassine EM
Egypt J Immunol; 2018 Jan; 25(1):35-43. PubMed ID: 30242996
[TBL] [Abstract][Full Text] [Related]
30. Serum soluble urokinase-type plasminogen activator receptor as a biological marker of bacterial infection in adults: a systematic review and meta-analysis.
Ni W; Han Y; Zhao J; Cui J; Wang K; Wang R; Liu Y
Sci Rep; 2016 Dec; 6():39481. PubMed ID: 27991579
[TBL] [Abstract][Full Text] [Related]
31. Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in systemic lupus erythematosus.
Toldi G; Szalay B; Bekő G; Bocskai M; Deák M; Kovács L; Vásárhelyi B; Balog A
Biomarkers; 2012 Dec; 17(8):758-63. PubMed ID: 23033975
[TBL] [Abstract][Full Text] [Related]
32. The diagnostic value of soluble urokinase plasminogen activator receptor compared with C-reactive protein and procalcitonin in children with febrile neutropenia.
Sirinoglu M; Soysal A; Karaaslan A; Kepenekli Kadayifci E; Cinel I; Koç A; Tokuç G; Yaman A; Haklar G; Şirikçi Ö; Turan S; Altınkanat Gelmez G; Söyletir G; Bakır M
Pediatr Hematol Oncol; 2016 Apr; 33(3):200-8. PubMed ID: 27057782
[TBL] [Abstract][Full Text] [Related]
33. Soluble urokinase plasminogen activator receptor informs on the progression course after multiple injuries.
Patrani M; Tsaganos T; Kotzampassi K; Paraschos M; Katsenos C; Giamarellos-Bourboulis EJ; Mandragos K
Biomarkers; 2016 Nov; 21(7):660-4. PubMed ID: 27121128
[TBL] [Abstract][Full Text] [Related]
34. Clinical value of soluble urokinase-type plasminogen activator receptor in predicting sepsis-associated acute kidney injury.
Zhang W; Gu Y; Zhou J; Wang J; Zhao X; Deng X; Li H; Yan L; Jiao X; Shao F
Ren Fail; 2024 Dec; 46(1):2307959. PubMed ID: 38289005
[TBL] [Abstract][Full Text] [Related]
35. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis.
Zimmermann HW; Koch A; Seidler S; Trautwein C; Tacke F
Liver Int; 2012 Mar; 32(3):500-9. PubMed ID: 22098627
[TBL] [Abstract][Full Text] [Related]
36. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
37. Predictive value of soluble urokinase plasminogen activator receptor, soluble ST2, and IL-33 in bronchopulmonary dysplasia.
Tunc T; Cekmez F; Yildirim S; Bulut O; Ince Z; Saldir M; Aydemir G; Yaman H; Coban A
Pediatr Res; 2014 Jun; 75(6):788-92. PubMed ID: 24603291
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic power of soluble urokinase plasminogen activator receptor (suPAR) for short-term mortality in patients seen in Emergency Departments due to infections].
Rubio Díaz R; de Rafael González E; Martín Torres E; Valera Núñez E; López Martos AM; Melguizo Melguizo D; Picazo Perea MP; López García PJ; Fuentes Bullejos P; Chafer Rudilla M; Carretero Gómez JF; Julián-Jiménez A
Rev Esp Quimioter; 2022 Feb; 35(1):50-62. PubMed ID: 34859658
[TBL] [Abstract][Full Text] [Related]
39. Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis.
Zhang Q; Li L; Chen H; Zhang G; Zhu S; Kong R; Chen H; Wang G; Sun B
J Clin Lab Anal; 2020 Mar; 34(3):e23097. PubMed ID: 31774228
[TBL] [Abstract][Full Text] [Related]
40. Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients.
Donadello K; Scolletta S; Taccone FS; Covajes C; Santonocito C; Cortes DO; Grazulyte D; Gottin L; Vincent JL
J Crit Care; 2014 Feb; 29(1):144-9. PubMed ID: 24120089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
